Difference between revisions of "Lymphoma"

Jump to navigation Jump to search
(more)
Line 212: Line 212:
==Plasmacytoma==
==Plasmacytoma==
===General===
===General===
*[[AKA]] ''plasma cell myleoma''.
*[[AKA]] ''plasma cell myeloma''.
*Malignancy derived from the plasma cells.
*Malignancy derived from the plasma cells.
*Histologic component of ''multiple myeloma''; to diagnose multiple myeloma other (non-pathology) criteria are needed.
*Histologic component of ''multiple myeloma''; to diagnose multiple myeloma other (non-pathology) criteria are needed.
Line 320: Line 320:
Features:
Features:
*Large cells with eosinophilic cytoplasm.
*Large cells with eosinophilic cytoplasm.
*Usu. appear cohesive.
*Usually appear cohesive.
*May be subcapsular.
*May be subcapsular.
*Large multinucleated cell - "wreath cell" - '''key feature'''.
*Large multinucleated cell - "wreath cell" - '''key feature'''.
Line 520: Line 520:
|-
|-
| Anaplastic large cell lymphoma
| Anaplastic large cell lymphoma
| size of cells ?
| large
| site ?
| deep & subcapsular sinuses of LN
| histomorphology ?
| eosinophilic cytoplasm, nucleoli, often cohesive, wreath cell (C-shaped nucleus)
| CD30+/-, Alk+/-
| CD30+/-, Alk+/-, CD4+, CD3-
| translocations ?
| t(2,5)(p23;q35)<ref name=pmid8547653>{{cite journal |author=Lamant L, Meggetto F, al Saati T, ''et al.'' |title=High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining |journal=Blood |volume=87 |issue=1 |pages=284–91 |year=1996 |month=January |pmid=8547653 |doi= |url=}}</ref>
| clinical ?
| clinical ?
| prevalence ?
| uncommon
| DDx ?
| carcinoma
|-
|-
| Extranodal NK / T cell lymphoma nasal type
| Extranodal NK / T cell lymphoma nasal type